title: Targeting B-cells in lupus nephritis: should cautious optimism remain?
authors: Nephrology Division, Department of Internal Medicine, The Wexner Medical Center, Ohio State University, Columbus, OH, USA. Rovin.1@osu.edu
authors: Brad H
authors: BH
authors: Rovin
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab